• Home
  • Browse Tenders
  • Pricing
  • How It Works
  • Use Cases
  • Sectors
  • Blog
  • Knowledge Hub
  • Competitor Intelligence
  • Pipeline Intelligence
  • About
  • FAQ
  • Contact
  • Get Started Free
  • Sign In

Compounded mAbs - Cancer Therapies

Tender opportunity published by Berkshire Healthcare NHS Foundation Trust on TenderSignal, the UK public sector tender monitoring platform.

Contracting Authority
Berkshire Healthcare NHS Foundation Trust
Deadline
22 June 2026
Contract Value
£21,600,000,000 – £21,600,000,000
Region
Bracknell
Contract Type
services
Source
FTS

Phamacy Procurement Contract - A ranked framework for the supply and delivery of Compounded Monoclonal Antibodies (mAbs) for Intravenous Infusion for Chemotherapy indications split into 2 lots: Lot 1: High Volume Products - 5 molecules / all brands Lot 2: Lower Volume Products - 13 molecules / all b

Sign up free to receive matched tender alerts like this one

Browse more UK public sector tenders · View pricing

  • Privacy Policy
  • Terms of Service
  • Contact
  • Sitemap